Skip to content

Tuesday, October 7, 2025

Latest:

Physician Assistants: Expanding access, elevating care
Eliciting and acting on “What Matters” as the foundation for age-friendly, person-centered care
Need to optimize drug design? COOKIE-Pro can help.
Baylor doctors find method to prescribe less opioids after lung transplant surgery
NIH awards Baylor more than $15 million to fund two rare diseases consortia

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

TopBP1

5D4 disrupts several molecular pathways, including MYC, that lead to cancer growth

October 26, 2023 5D4, Breast Cancer, cancer inhibitor, MYC, ovarian cancer, PARP inhibitor, Research, TopBP1

The findings strongly support the potential use of TopBP1 inhibitors as a targeted cancer therapy.

From the Labs: Image of the Month

From the Labs: a closer look at Barrett's esophagus

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951